These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 35069993

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M.
    World J Gastroenterol; 2013 Nov 14; 19(42):7327-40. PubMed ID: 24259964
    [Abstract] [Full Text] [Related]

  • 3. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
    Fousekis FS, Theopistos VI, Katsanos KH, Tsianos EV, Christodoulou DK.
    Gastroenterology Res; 2018 Apr 14; 11(2):83-94. PubMed ID: 29707074
    [Abstract] [Full Text] [Related]

  • 4.
    Malik TF, Aurelio DM.
    ; 2024 01 14. PubMed ID: 33760556
    [Abstract] [Full Text] [Related]

  • 5. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
    Navaneethan U, Shen B.
    Inflamm Bowel Dis; 2010 Sep 14; 16(9):1598-619. PubMed ID: 20198712
    [Abstract] [Full Text] [Related]

  • 6. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients.
    Silva J, Brito BS, Silva INN, Nóbrega VG, da Silva MCSM, Gomes HDN, Fortes FM, Pimentel AM, Mota J, Almeida N, Surlo VC, Lyra A, Rocha R, Santana GO.
    Biomed Res Int; 2019 Sep 14; 2019():7604939. PubMed ID: 30834274
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Liver manifestations and complications in inflammatory bowel disease: A review.
    Gaspar R, Branco CC, Macedo G.
    World J Hepatol; 2021 Dec 27; 13(12):1956-1967. PubMed ID: 35070000
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatopancreatobiliary manifestations of inflammatory bowel disease.
    Nakamura K, Ito T, Kotoh K, Ihara E, Ogino H, Iwasa T, Tanaka Y, Iboshi Y, Takayanagi R.
    Clin J Gastroenterol; 2012 Feb 27; 5(1):1-8. PubMed ID: 26181867
    [Abstract] [Full Text] [Related]

  • 17. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J, Van Steenbergen W, Van Pelt J, Laleman W, Hoffman I, Geboes K, Vermeire S, Nevens F.
    Aliment Pharmacol Ther; 2016 Mar 27; 43(5):612-20. PubMed ID: 26748470
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
    Azzam N, AlRuthia Y, Alharbi O, Aljebreen A, Almadi M, Loftus EV.
    Hepatol Int; 2020 Dec 27; 14(6):1114-1124. PubMed ID: 33369708
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.